Combined use of beta-adrenergic agonists and methyl xanthines.
D000318:Adrenergic beta-Agonists / Q000008:administration & dosage* / Q000009:adverse effects; D000628:Aminophylline / Q000008:administration & dosage; D000818:Animals; D001249:Asthma / Q000150:complications / Q000188:drug therapy; D004285:Dogs; D006321:Heart / Q000187:drug effects*; D006331:Heart Diseases / Q000139:chemically induced*; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D011817:Rabbits; D051381:Rats; D013806:Theophylline / Q000008:administration & dosage; D014970:Xanthines / Q000008:administration & dosage*
D000318:Adrenergic beta-Agonists; D007328:Insulin; D014970:Xanthines; D000628:Aminophylline; C008514:methylxanthine; D013806:Theophylline